Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Aug;56(4):492-6.
doi: 10.1111/ped.12420.

Biochemical and clinical features of hereditary hyperprolinemia

Affiliations
Free PMC article

Biochemical and clinical features of hereditary hyperprolinemia

Hiroshi Mitsubuchi et al. Pediatr Int. 2014 Aug.
Free PMC article

Abstract

There are two classifications of hereditary hyperprolinemia: type I (HPI) and type II (HPII). Each type is caused by an autosomal recessive inborn error of the proline metabolic pathway. HPI is caused by an abnormality in the proline-oxidizing enzyme (POX). HPII is caused by a deficiency of Δ-1-pyrroline-5-carboxylate (P5C) dehydrogenase (P5CDh). The clinical features of HPI are unclear. Nephropathy, uncontrolled seizures, mental retardation or schizophrenia have been reported in HPI, but a benign phenotype without neurological problems has also been reported. The clinical features of HPII are also unclear. In addition, the precise incidences of HPI and HPII are unknown. Only two cases of HPI and one case of HPII have been identified in Japan through a questionnaire survey and by a study of previous reports. This suggests that hyperprolinemia is a very rare disease in Japan, consistent with earlier reports in Western countries. The one case of HPII found in Japan was diagnosed in an individual with influenza-associated encephalopathy. This suggests that HPII might reduce the threshold for convulsions, thereby increasing the sensitivity of individuals with influenza-associated encephalopathy. The current study presents diagnostic criteria for HPI and HPII, based on plasma proline level, with or without measurements of urinary P5C. In the future, screening for HPI and HPII in healthy individuals, or patients with relatively common diseases such as developmental disabilities, epilepsy, schizophrenia or behavioral problems will be important.

Keywords: P5C; hyperprolinemia type I; hyperprolinemia type II; inborn error of metabolism; proline.

PubMed Disclaimer

Figures

Fig 1
Fig 1
l-Proline metabolism and enzyme deficiencies. The metabolism of proline in mammals involves two other amino acids, glutamate and ornithine, and six enzymes. Conversion of P5C to glutamic-γ-semi-aldehyde is a non-enzymatic step. HPI, hyperprolinemia type I; HPII, hyperprolinemia type II; P5C, Δ-1-pyrroline-5-carboxylate; TCA, tricarboxylic acid.
Fig 2
Fig 2
Diagnostic criteria for hyperprolinemia types I and II. P5C, Δ-1-pyrroline-5-carboxylate.

References

    1. Phang JM, Hu C-A, Valle D. Disorders of proline and hydroxyproline metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill; 2001. pp. 1821–1838. 8th edn.
    1. Mitsubuchi H, Nakamura K, Matsumoto S, Endo F. Inborn errors of proline metabolism. J. Nutr. 2008;138:2016S–2020. - PubMed
    1. Schafer IA, Scriver CR, Efron ML. Familial hyperprolinemia, cerebral dysfunction and renal anomalies occurring in a family with hereditary nephropathy and deafness. N. Engl. J. Med. 1962;267:51–60. - PubMed
    1. Kopelman H, Asatoor AM, Milne MD. Hyperprolinaemia and hereditary nephritis. Lancet. 1964;13:1075–1079. - PubMed
    1. Efron ML. Familial hyperprolinemia. Report of a second case, associated with congenital renal malformations, hereditary hematuria and mild mental retardation, with demonstration of an enzyme defect. N. Engl. J. Med. 1965;272:1243–1254. - PubMed

Publication types

MeSH terms

Supplementary concepts